The startup develops therapeutics that enhance proteasome activity to eliminate misfolded proteins associated with age-related diseases and cancer. By utilizing human skin fibroblasts for precise modeling, the company aims to improve cellular cleanup and promote protein homeostasis, addressing the accumulation of harmful proteins in cells and tissues.
Funding
Funding not disclosed
Founders
Product
Problem
The accumulation of misfolded proteins within cells is a hallmark of aging and contributes to the development of various age-related diseases. Current therapeutic approaches have limitations in effectively enhancing the cellular mechanisms responsible for eliminating these harmful proteins.
Solution
Longevity SIA is developing therapeutics designed to enhance proteasome activity, the cellular process responsible for degrading misfolded proteins. By improving the efficiency of this protein degradation pathway, the company aims to address the underlying cause of age-related diseases and promote cellular health. Their approach involves identifying and optimizing natural compounds and small molecules that can stimulate proteasome production and activity. The company utilizes human skin fibroblasts in their research to create a precise model for testing and optimizing their therapeutic interventions, ensuring effective reduction of misfolded proteins.
Target Audience
The primary target audience includes individuals at risk of or affected by age-related diseases, as well as pharmaceutical and cosmetic companies interested in novel therapies for promoting cellular health and longevity.
Features
- Focus on enhancing proteasome activity to eliminate misfolded proteins.
- Utilizes human skin fibroblasts for precise modeling of cellular processes.
- Rigorous testing of natural compounds and small molecules to identify promising therapeutic candidates.
- Aims to improve cellular cleanup and promote protein homeostasis.
- Development of therapies targeting proteostasis disruption associated with aging.
- Determination of optimal ingredient concentration and delivery methods.